Does OLUTASIDENIB Cause Product use issue? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product use issue have been filed in association with OLUTASIDENIB (REZLIDHIA). This represents 3.3% of all adverse event reports for OLUTASIDENIB.
7
Reports of Product use issue with OLUTASIDENIB
3.3%
of all OLUTASIDENIB reports
2
Deaths
1
Hospitalizations
How Dangerous Is Product use issue From OLUTASIDENIB?
Of the 7 reports, 2 (28.6%) resulted in death, 1 (14.3%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLUTASIDENIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does OLUTASIDENIB Cause?
Off label use (59)
Hospitalisation (27)
Death (24)
Nausea (23)
Fatigue (21)
Product dose omission issue (19)
Product prescribing issue (15)
Constipation (14)
Transfusion (11)
Pneumonia (9)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which OLUTASIDENIB Alternatives Have Lower Product use issue Risk?
OLUTASIDENIB vs OMACETAXINE MEPESUCCINATE
OLUTASIDENIB vs OMADACYCLINE
OLUTASIDENIB vs OMALIZUMAB
OLUTASIDENIB vs OMAVELOXOLONE
OLUTASIDENIB vs OMBITASVIR